Evidence map›Paper›PMID 34900084›Full record

ArticleOxidative medicine and cellular longevity2021

Mangiferin Inhibits PDGF-BB-Induced Proliferation and Migration of Rat Vascular Smooth Muscle Cells and Alleviates Neointimal Formation in Mice through the AMPK/Drp1 Axis.

Qi Wu, Yuanyang Chen, Zhiwei Wang, Xin Cai, Yanjia Che, Sihao Zheng, Shun Yuan, Xiaohan Zhong

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Silencing ofActa biochimica et biophysica Sinica · 2024
    Article
  3. Mitochondrial influences on smooth muscle phenotype.American journal of physiology. Cell physiology · 2024
    Review
  4. Review
  5. Receptor Tyrosine Kinase: Still an Interesting Target to Inhibit the Proliferation of Vascular Smooth Muscle Cells.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2023
    Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Qi WuDepartment of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Yuanyang ChenDepartment of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Zhiwei WangDepartment of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.ORCID https://orcid.org/0000-0001-5643-9344
Xin CaiDepartment of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Yanjia CheDepartment of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Sihao ZhengDepartment of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Shun YuanDepartment of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Xiaohan ZhongDepartment of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mangiferin is a naturally occurring xanthone C-glycoside that is widely found in various plants. Previous studies have reported that mangiferin inhibits tumor cell proliferation and migration. Excessive proliferation and migration of vascular smooth muscle cells (SMCs) is associated with neointimal hyperplasia in coronary arteries. However, the role and mechanism of mangiferin action in neointimal hyperplasia is still unknown. In this study, a mouse carotid artery ligation model was established, and primary rat smooth muscle cells were isolated and used for mechanistic assays. We found that mangiferin alleviated neointimal hyperplasia, inhibited proliferation and migration of SMCs, and promoted platelets derive growth factors-BB- (PDGF-BB-) induced contractile phenotype in SMCs. Moreover, mangiferin attenuated neointimal formation by inhibiting mitochondrial fission through the AMPK/Drp1 signaling pathway. These findings suggest that mangiferin has the potential to maintain vascular homeostasis and inhibit neointimal hyperplasia.

Indexed as

AMP-Activated Protein KinasesAnimalsBecaplerminCarotid ArteriesCell DedifferentiationCell MovementCell ProliferationCells, CulturedDynaminsHyperplasiaMaleMatrix Metalloproteinase 2MiceMice, Inbred C57BLMitochondrial DynamicsMuscle, Smooth, VascularAMP-Activated Protein KinasesBecaplerminDnm1l protein, mouseDynaminsmangiferinMatrix Metalloproteinase 2Proliferating Cell Nuclear AntigenReactive Oxygen SpeciesXanthones

Identifiers

PMID34900084
PMCPMC8664531
OpenAlexW4200209894

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.